Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Study of Photodynamic Therapy With Levulan Kerastick Topical Solution + Blue Light Versus Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities

NCT02137785 is registered in ClinicalTrials.gov with DUSA Pharmaceuticals, Inc. as lead sponsor.

NCT NCT02137785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02137785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Study of Photodynamic Therapy With Levulan Kerastick Topical Solution + Blue Light Versus Topical Solution Vehicle + Blue Light for the Treatment of Actinic Keratoses on the Upper Extremities
Lead sponsor
DUSA Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2014
Completion date
March 31, 2015
Enrollment
269 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis